UPDATE: JPMorgan Downgrades Magenta Therapeutics (MGTA) to Neutral
Tweet Send to a Friend
(Updated - August 3, 2021 4:35 AM EDT)
JPMorgan analyst Jessica Fye downgraded Magenta Therapeutics (NASDAQ: MGTA) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Jessica Fye downgraded Magenta Therapeutics (NASDAQ: MGTA) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
